ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Sunday, 15 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Business Update

Dr. Reddy's Laboratories Business Update

USFDA classified Dr Reddy's Bachupally facility inspection as Voluntary Action Indicated and closed it. The outcome follows an August 2026 intimation on the same inspection.

Source

BSE filing, NSE: DRREDDY. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Dr. Reddy's Laboratories Ltd: key numbers

Share price
₹1,380.00
Market cap
₹1,15,185 Cr
Revenue (annual)
₹33,700 Cr
Net profit (annual)
₹4,196 Cr
P/E (TTM)
41.1×Sector 43.7×
Promoter holding
26.63%-0.01% QoQ
FII holding
20.30%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Dr. Reddy's Laboratories Ltd

All →
09:47 IST BSE
Regulatory Approval

Dr. Reddy's Laboratories Regulatory Approval

Dr. Reddy's Laboratories received marketing authorization from Brazil's ANVISA for its generic semaglutide injection. The approval targets Brazil's diabetes market, estimated at approximately USD 244.6 million.

Other business update announcements

All →
14:35 IST BSE
Business UpdateRasi Electrodes Ltd RASIELEC

Rasi Electrodes Business Update

Rasi Electrodes' board approved a related-party contract with Kashyap Wire Products, a proprietorship of the MD's wife, for solar power supply. The company states the contract is not material, with estimated billing of about Rs 1 lakh per month and a Rs 3.50 lakh security deposit.

Execution
5 years from date in the agreement, renewable for a further 5 years